FMC Corporation

FMC Corporation is an American agricultural sciences company, founded in 1883. Having divested all non-agricultural businesses, FMC is now a pure-play crop protection innovator headquartered in Philadelphia, Pennsylvania. The company operates 21 global manufacturing sites and 17 R&D facilities with 5,700 employees, generating US$3.47 billion in 2025 revenue.

Strengths:
• Unmatched diamide insecticide patent moat: Flagship Rynaxypyr® (chlorantraniliprole) remains the gold standard in insect control chemistry, sustaining adjusted EBITDA margins at 22% even during a severe industry downturn—demonstrating irreplaceable product technology premium.
• Decisive supply chain restructuring under "Project Foundation": Aggressive relocation of two core active ingredient productions to low-cost regions, combined with Indian business divestiture, is expected to structurally improve cost competitiveness and refocus the portfolio on patent-protected molecules.
• Direct-to-grower commercial model in Brazil: Establishment of a dedicated large-farm technical sales force in Brazil's corn/soybean belt eliminates intermediary margins, offering a scalable blueprint for capturing value in the world's largest crop protection market.

Weaknesses:
• Severe revenue contraction and massive GAAP net loss: Full-year GAAP revenue dropped 18% to US$3.47 billion (8% organic decline ex-divestitures), while a US$2.579 billion GAAP net loss—driven by goodwill impairment from stock price decline and Indian asset revaluation—highlighted acute market exposure.
• Single-molecule dependency and patent cliff risk: Rynaxypyr® patent expirations in key markets within this decade threaten the core franchise, and the replacement pipeline's commercial scale remains unproven under current R&D investment levels.